blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1153613

EP1153613 - PERCUTANEOUS ABSORPTION PREPARATIONS OF COMPOUND HAVING ANGIOTENSIN II RECEPTOR ANTAGONISM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.09.2011
Database last updated on 24.08.2024
Most recent event   Tooltip17.05.2013Lapse of the patent in a contracting state
New state(s): LU
published on 19.06.2013  [2013/25]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome, Chuo-ku
Osaka / JP
[2005/02]
Former [2001/46]For all designated states
Takeda Chemical Industries, Ltd.
1-1 Doshomachi 4-chome, Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
Inventor(s)01 / IGA, Katsumi
1-A-808, Satsukigaokanishi
Suita-shi, Osaka 563-0833 / JP
02 / SUZUKI, Yasuyuki
20-7-503, Koshienguchi 3-chome
Nishinomiya-shi, Hyogo 663-8113 / JP
03 / NAKA, Takehiko
4-15-711, Kamokogahara 1-chome, Higashinada-ku
Kobe-shi, Hyogo 658-0064 / JP
 [2001/46]
Representative(s)Best, Michael, et al
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
[N/P]
Former [2001/46]Best, Michael, Dr., et al
Lederer, Keller & Riederer Patentanwälte Prinzregentenstrasse 16
80538 München / DE
Application number, filing date00904029.618.02.2000
[2001/46]
WO2000JP00926
Priority number, dateJP1999004239619.02.1999         Original published format: JP 4239699
[2001/46]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0048634
Date:24.08.2000
Language:EN
[2000/34]
Type: A1 Application with search report 
No.:EP1153613
Date:14.11.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 24.08.2000 takes the place of the publication of the European patent application.
[2001/46]
Type: B1 Patent specification 
No.:EP1153613
Date:10.11.2010
Language:EN
[2010/45]
Search report(s)International search report - published on:JP24.08.2000
(Supplementary) European search report - dispatched on:EP04.02.2005
ClassificationIPC:A61K45/00, A61K9/70, A61K47/14, A61K47/10, A61K47/16, A61K31/4178, A61K31/4245, A61P43/00, C07D403/10, C07D413/10
[2005/12]
CPC:
A61K9/7061 (EP,US); A61K31/4178 (EP,US); A61K31/4245 (EP,US);
A61K47/10 (EP,US); A61K47/14 (EP,US); A61K47/16 (EP,US);
A61K9/0014 (EP,US); A61P43/00 (EP) (-)
Former IPC [2001/46]A61K45/00, A61K9/70, A61K47/14, A61K47/10, A61K47/16, A61K31/4178, A61K31/4245, A61P43/00, // (C07D403/10, 413:10)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/46]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PRÄPARATIONEN ZUR PERKUTANEN AUFNAHME VON ZUSAMMNESETZUNGEN DIE EINEN ANGIOTENSIN-II-REZEPTORANTAGONISMUS AUFWEISEN[2001/46]
English:PERCUTANEOUS ABSORPTION PREPARATIONS OF COMPOUND HAVING ANGIOTENSIN II RECEPTOR ANTAGONISM[2001/46]
French:PREPARATIONS D'ADSORPTION PERCUTANEE DE COMPOSE AYANT UN ANTAGONISME DE RECEPTEUR D'ANGIOTENSINE II[2001/46]
Entry into regional phase10.08.2001Translation filed 
10.08.2001National basic fee paid 
10.08.2001Search fee paid 
10.08.2001Designation fee(s) paid 
10.08.2001Examination fee paid 
Examination procedure23.03.2000Request for preliminary examination filed
International Preliminary Examining Authority: JP
10.08.2001Examination requested  [2001/46]
05.11.2001Amendment by applicant (claims and/or description)
23.09.2005Despatch of a communication from the examining division (Time limit: M06)
21.03.2006Reply to a communication from the examining division
11.09.2007Despatch of a communication from the examining division (Time limit: M06)
29.01.2008Reply to a communication from the examining division
10.02.2010Communication of intention to grant the patent
14.06.2010Fee for grant paid
14.06.2010Fee for publishing/printing paid
Opposition(s)11.08.2011No opposition filed within time limit [2011/42]
Fees paidRenewal fee
31.01.2002Renewal fee patent year 03
30.01.2003Renewal fee patent year 04
29.01.2004Renewal fee patent year 05
28.01.2005Renewal fee patent year 06
31.01.2006Renewal fee patent year 07
29.01.2007Renewal fee patent year 08
13.02.2008Renewal fee patent year 09
13.02.2009Renewal fee patent year 10
16.02.2010Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT10.11.2010
BE10.11.2010
CY10.11.2010
DK10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
GR11.02.2011
IE18.02.2011
LU18.02.2011
ES21.02.2011
MC28.02.2011
PT10.03.2011
[2013/25]
Former [2012/08]AT10.11.2010
BE10.11.2010
CY10.11.2010
DK10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
GR11.02.2011
IE18.02.2011
ES21.02.2011
MC28.02.2011
PT10.03.2011
Former [2011/45]AT10.11.2010
BE10.11.2010
CY10.11.2010
DK10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
GR11.02.2011
ES21.02.2011
MC28.02.2011
PT10.03.2011
Former [2011/40]AT10.11.2010
BE10.11.2010
CY10.11.2010
DK10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
GR11.02.2011
ES21.02.2011
PT10.03.2011
Former [2011/35]AT10.11.2010
BE10.11.2010
CY10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
GR11.02.2011
ES21.02.2011
PT10.03.2011
Former [2011/31]AT10.11.2010
CY10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
GR11.02.2011
PT10.03.2011
Former [2011/24]CY10.11.2010
FI10.11.2010
NL10.11.2010
SE10.11.2010
PT10.03.2011
Documents cited:Search[X]WO9817315  (ALZA CORP [US]) [X] 1-40 * page 1, lines 6-9 * * page 6, line 27 - page 7, line 6; claim 12 * * page 7, line 21 *;
 [PX]WO9915210  (NOVEN PHARMA [US], et al) [PX] 1-40 * page 29, lines 26-35 * * page 54, paragraph L - page 55, paragraph 1 * * page 55, paragraph L - page 56, paragraph 1 ** page 55 last full paragraph - page 56 paragraph 1 *
International search[Y]JPS62223118  (HISAMITSU PHARMACEUTICAL CO);
 [Y]EP0459136  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [Y]EP0520423  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [X]EP0573271  (LILLY CO ELI [US]);
 [X]EP0574174  (LILLY CO ELI [US]);
 [X]US5274104  (ARNAUD JOELLE [FR], et al);
 [X]JPH0673008  (MEIJI SEIKA KAISHA);
 [X]JPH072776  (MEIJI SEIKA KAISHA);
 [X]WO9506410  (SMITHKLINE BEECHAM CORP [US], et al);
 [Y]JPH07330627  (SANWA KAGAKU KENKYUSHO CO);
 [Y]JPH0840896  (TEISAN SEIYAKU KK);
 [X]JPH09100240  (SANOFI SA);
 [X]WO9734597  (SANOFI SA [FR]);
 [Y]JPH09299445  (SEKISUI CHEMICAL CO LTD);
 [Y]EP0879597  (TSUMURA & CO [JP], et al);
 [XP]WO9956734  (HEXAL AG [DE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.